Skip to main content
. Author manuscript; available in PMC: 2017 Feb 1.
Published in final edited form as: Stroke. 2016 Jan 5;47(2):490–497. doi: 10.1161/STROKEAHA.115.011223

Figure 3.

Figure 3

Administration of LXA4 decreased brain water content (A) and blood brain barrier permeability (B), improved neurological functions (C) and reduced mortality (D) at 24 hours after SAH. n=6 for each group. *p<0.05 vs. Sham, #p<0.05 vs. SAH+vehicle.